The closely related small GTP-binding proteins H-Ras and R-Ras have opposing eects on the regulation of integrin cell adhesion receptors. To gain insight into the properties of R-Ras with respect to the regulation of integrin function and interactions with downstream eectors we performed an analysis of R-Ras variants containing mutations in the eector binding domain and C-terminal prenylation site. We found that the activation of the downstream eector PI 3-kinase was sensitive to mutations in the eector binding domain, as was the binding to the eectors, Ral-GDS, Raf-1 and the novel eector Nore1. Furthermore, speci®c mutations in the eector binding loop and C-terminal prenylation motif impaired the ability of R-Ras to regulate integrin function in CHO cells. However, the ability of the R-Ras eector loop mutants to bind, and activate known eectors did not correlate with their ability to regulate integrin function. Thus, the known R-Ras eectors are not critical for regulating integrin activation, at least in CHO cells. Consequently, these studies provide insight into the structural basis of the interactions between R-Ras and its candidate eectors and suggest the existence of novel mechanisms through which this GTPase could regulate cell adhesion. Oncogene (2000) 19, 4961 ± 4969.
Introduction
R-Ras was originally identi®ed because of its similarity to the H-Ras, K-Ras and N-Ras oncogenes, being approximately 55% identical to each (Lowe et al., 1987) . Ras proteins function as molecular switches that are controlled by a GDP/GTP binding cycle, coupling to and activating downstream eectors when in the activated GTP-bound conformation (Bos, 1997) . RRas and the other Ras proteins have similar eector binding domains, and bind to common downstream eectors when in the GTP-bound conformation. Both H-Ras and R-Ras interact with the p110 catalytic subunit of PI 3-kinase in vitro, and induce the elevation of the levels of PI 3-kinase lipid products in vivo (Rodriguez-Viciana et al., 1994; Marte et al., 1997) . Like the other Ras proteins, R-Ras interacts with the Raf serine/threonine kinases in vitro Rey et al., 1994) . However, R-Ras, in contrast to Ras, has not been reported to markedly activate Raf, or the ERK family of MAP kinases in vivo (Sethi et al., 1999; Marte et al., 1997) . R-Ras can also interact with the Ras eector Ral-GDS and other members of the family of exchange factors for the Ras-related small GTP-binding protein Ral (Wolthuis et al., 1996; Urano et al., 1996; Kikuchi et al., 1994; Peterson et al., 1996; Hu et al., 1997) . However, R-Ras appears to be unable to activate Ral-GDS in intact cells (Urano et al., 1996) .
H-Ras and R-Ras manifest distinct biological properties. For example, R-Ras is unable to transform Rat1 ®broblasts and furthermore, R-Ras transformed NIH3T3 cells do not display some of the morphological eects associated with H-Ras transformed cells (Cox et al., 1994; Lowe and Goeddel, 1987) . In addition, in epithelial cells, activated H-Ras and RRas have dierent eects on cell migration and tubule formation (Khwaja et al., 1998; Keely et al., 1999) .
R-Ras and H-Ras have distinct roles in regulating integrin function (Kinashi et al., 2000; Zou et al., 1999; Sethi et al., 1999; Zhang et al., 1996) . A characteristic feature of integrins is their ability to dynamically regulate their anity for soluble ligands in response to intracellular signals, a process de®ned as`activation'. Thus far, H-Ras has been shown to suppress integrin activation in Chinese Hamster ovary (CHO) cells via its eector serine/threonine kinase Raf-1 (Hughes et al., 1997) and activated R-Ras can antagonize the Ras/Raf suppressor pathway (Sethi et al., 1999) . In both myeloid cells and bone marrow derived mast cells activated R-Ras can stimulate both integrin a5b1 activation and a5b1 dependent-adhesion to ®bronectin (Kinashi et al., 2000; Zhang et al., 1996) .
However, the exact mechanism by which R-Ras regulates integrin function remains obscure and it is not clear if it is solely mediated by the GTP-dependent activation of downstream eectors, a process dependent on a C-terminal prenylated motif required for membrane localization and a core eector binding domain. To address this question we generated R-Ras variants containing mutations in the eector binding domain, and in the C-terminal prenylated motif, and analysed their ability to regulate integrin activation in CHO cells.
A mutation in the eector loop (D64E) blocked the ability of R-Ras to regulate integrins, suggesting that the integrin eect requires the activation of a downstream eector. In contrast, other mutations that markedly reduced activation of the PI 3-kinase eector Akt and impaired binding to Ral-GDS, Raf-1 and Nore1 were able to regulate integrins, indicating that these eectors are not essential for integrin activation in CHO cells. In addition, we found that the prenylation of R-Ras is necessary to rescue integrin suppression. In summary, these studies show that membrane-localization and the conserved eector loops of R-Ras are involved in regulating integrin function and provide critical insight into how R-Ras interacts with its downstream eectors.
Results

Characterization of R-Ras effector loop mutants
As the core eector binding domain of R-Ras is identical to H-Ras, H-Ras was used as a template to construct the following point mutations in the RRas(G38V) eector domain: (1) R-Ras(E63G), analogous to H-Ras(E37G), a mutant that activates Ral-GDS but not Raf or PI 3-Kinase (White et al., 1995; Rodriguez-Viciana et al., 1997) ; (2) R-Ras(D64A), analogous to H-Ras(D38A), a mutant, that does not activate Raf, PI 3-Kinase or Ral-GDS (RodriguezViciana et al., 1997); (3) R-Ras(D64E), analogous to H-Ras(D38E), a mutant that activates only Raf but not Ral-GDS or PI 3-Kinase (Rodriguez-Viciana et al., 1997); (4) R-Ras(Y66C), analogous to H-Ras(Y40C), a mutant which activates PI 3-Kinase but not Ral-GDS or Raf (Joneson et al., 1996) (Figure 1) .
GTP-bound R-Ras binds and activates the p110 catalytic subunit of PI 3-kinase a . To gain further insight into activation of PI 3-kinase by R-Ras, we tested the capacity of the R-Ras eector loop mutants to activate the PI 3-kinase eector Akt, (PKB). As expected R-Ras(G38V) strongly stimulated PI 3-kinase activation in COS7 cells. Of the R-Ras mutations, E63G only mildly impaired the ability of RRas to activate PI 3-kinase. In contrast, the D64A, D64E and Y66C mutations signi®cantly aected the ability of R-Ras(G38V) to activate Akt (Figure 2a,  Figure b ). We also tested the capacity of the R-Ras eector loop mutants to activate Akt in CHO cells. In this cell line we found similar results to those observed in COS7 cells. Speci®cally, we found that the E63G mutation slightly reduced the ability of R-Ras to activate PI 3-kinase, whereas the D64A, D64E and Y66C mutations had more profound eects, signi®-cantly reducing the ability of R-Ras(G38V) to activate Akt (data not shown). R-Ras(G38V) does not activate ERK2 MAP kinase (Sethi et al., 1999; Marte et al., 1997; Hu et al., 1997) . However, mutations in the eector domain of R-Ras could generate a variant of R-Ras that activates the ERK2 MAP kinase pathway. We therefore tested the ability of the R-Ras eector loop mutants to activate ERK2 MAP kinase, but neither R-Ras(G38V) nor the various R-Ras eector loop mutants activated ERK2 MAP kinase (Figure 3) . Thus, the eector loop mutants did not confer the capacity to activate ERK2 MAP kinase to R-Ras.
Ral-GDS, a Ras eector, also interacts with GTPbound R-Ras . In yeast Figure 1 The eector binding domain of Ras proteins. Multiple, distinct sequences of Ras proteins are involved in interactions with eectors. The core sequences, residues 58 ± 66 (shaded) of RRas, identical in H-Ras and R-Ras, are thought to represent a common eector binding site for all of the Ras family members. The H-Ras mutations used to identify those residues critical for interactions with Raf-1, Ral-GDS and PI 3-kinase are indicated with an arrow Figure 2 The activation of Akt by R-Ras eector loop mutants. (a) COS7 cells were transfected with a vector encoding HA-tagged Akt plus plasmids encoding R-Ras(G38V) or the indicated R-Ras mutants. Akt activity was measured by phosphorylation of histone 2B using an immuno-complex kinase assay. The extent of histone 2B phosphorylation was determined by densitometry analysis and is expressed as fold activation relative to the control (HA-Akt alone). The values are corrected for variation in the amounts of HA-Akt recovered in the immunoprecipitates. Immunoblots illustrating the expression levels of HA-tagged Akt and myc-tagged R-Ras are depicted in the lower panels. (b) Akt phosphorylation was measured in COS7 cells transfected with HA-tagged Akt and plasmids encoding R-Ras(G38V) or the indicated R-Ras eector loop mutant. Twenty-four hours post transfection the cells were placed in media containing 0.5% FCS and 48 h after transfection the cells were lysed and 30 mg of cell lysate was resolved on 4 ± 20% SDS gel and transferred to a nitrocellulose membrane. The blots were then probed with a polyclonal antibody speci®c for phosphorylated Akt (upper panel). The blots were then stripped and re-probed with the anti-HA antibody 12CA5 to determine the expression of HA-Akt (lower panel). Depicted is the results of one of three representative experiments two-hybrid analysis R-Ras(G38V) interacts eciently with the RBD (Ras binding domain) of Ral-GDS, however, all of the eector loop mutants, with the exception of E63G, appeared to be unable to interact with the Ras binding domain (RBD) of Ral-GDS (Figure 4a ). These data suggest that the majority of the eector loop mutants are unable to interact with Ral-GDS, however, these studies are limited by the absence of data demonstrating that the dierent R-Ras fusion proteins were equally expressed and functional in yeast.
To address this issue we assessed whether interactions between the Ral-GDS RBD and the R-Ras eector loop mutations could be detected in vitro using a ligand blotting technique (Park and Weinberg, 1995) . Consistent with the results from the two-hybrid studies only R-Ras(G38V), but not the D64A, D64E or Y66C mutations showed detectable interaction with the RBD of Ral-GDS (Figure 4b ). In order to assess the functionality of these eector loop mutants, we examined their ability to bind GTP. All the mutants with the exception of R-Ras(Y66C) bound GTP with an eciency similar to R-Ras(G38V), suggesting that the recombinant R-Ras eector loop mutants were folded and functional with respect to nucleotide binding (Table 1) .
Using both the two-hybrid and ligand blotting assays we also tested the ability of activated R-Ras and the various eector loop mutants to interact with the RBD of Raf-1. We found R-Ras(G38V) interacted very weakly with Raf-1, and no interaction was detectable with any of the eector loop mutants tested (data not shown). However, in both assay systems a strong interaction was observed between H-Ras(G12V) and the RBD of Raf-1 (data not shown) demonstrating that the Raf-1 RBD was functional.
Identification of additional R-Ras effectors
Previous work has suggested the existence of R-Ras eectors other than Raf, Ral-GDS or PI 3-kinase Figure 3 The activation of ERK2 MAP-kinase by R-Ras eector loop mutants. MAP-kinase activity was measured in COS-7 cells transfected with HA-tagged ERK2 plus plasmids encoding H-Ras(G12V) or the indicated R-Ras variants. Twentyfour hours post transfection the cells were placed in media containing 0.5% FCS and 48 h after transfection the cells were lysed and transfected ERK2 was immunoprecipitated with anti-HA antibody, 12CA5. ERK2 activity was assessed via an immuno-complex kinase assay using myelin basic protein (MBP) as a substrate. The extent of MBP phosphorylation was determined by densitometry analysis and is expressed as fold activation relative to basal (HA-ERK2) alone). Depicted is the mean increase in ERK2 activation, relative to basal, +s.e. for three independent determinations. For each assay the amount of precipitated ERK2 was the same (not shown). In addition, H-Ras and R-Ras expression was the same in all assays (not shown) The interaction of the Ral-GDS RBD with R-Ras(G38V), R-Ras(G38V, D64A) and RRas(G38V, D64E) in vitro. Five mg of whole cell lysate from E. coli expressing the Ral-GDS RBD as a GST fusion protein was separated on a 4 ± 20% gradient gel and transferred to nitrocellulose membranes. Following a denaturation and renaturation procedure the membrane bound proteins were probed with 32 P-labeled GST R-Ras(G38V), GST R-Ras(G38V, D64A) and R-Ras(G38V, D64E) Similar results were obtained with RRas(G38V, Y66C) (not shown). The GST-R-Ras fusion proteins contain a consensus protein kinase A phosphorylation site at their N-terminus which allows them to be labeled with 32 P in vitro. The speci®c activities of all the 32 P-labeled R-Ras fusion proteins were comparable. 32 P-labeled GST did not react with Ral-GDS RBD in this assay (not shown) 
H]GTP to GST-R-Ras fusion proteins
Per cent coupling efficiency Control GST 0.9 R-Ras V38 68.9 R-Ras V38 D64A
29.1 R-Ras V38 D64E 85.9 R-Ras V38 Y66C 3.4 (Sethi et al., 1999) . Consequently, we used a yeast-two hybrid screen to search for additional R-Ras interacting proteins. In two independent screens we isolated cDNAs encoding Nore1, a protein previously identi®ed as an H-Ras eector (Vavvas et al., 1998) . The interaction of Nore1 with R-Ras was GTP-dependent, since Nore1 failed to bind to R-Ras (T43N) ( Figure 5 ). The T43N mutation is predicted to be unable to bind GTP and have a signi®cantly reduced anity for GDP (Cox et al., 1995) . Using yeast-two hybrid analysis we examined the ability of the dierent R-Ras eector loop mutants to bind Nore1 and found that only the E63G mutant was capable of interacting with Nore1 ( Figure 5 ). Furthermore, from these screens we also isolated the Ral Guanine nucleotides exchangers (RalGEF) Ral-GDS , Rgl II (Peterson et al., 1996) and Rlf (Wolthuis et al., 1996) , which are known H-Ras eectors. Each of these Ral GEFs failed to bind to R-Ras(T43N) thus con®rming the speci®city of the interaction. Taken together these results validate the capacity of a yeast two hybrid screen to isolate RRas eectors and identify Nore1 as a novel eector. Furthermore, the interaction of Nore1 with R-Ras is highly sensitive to eector loop mutations.
Role of the effector loop in R-Ras regulation of integrin activation
We have previously shown that activated variants of H-Ras or Raf-1 can suppress integrin activation in CHO cells and that R-Ras(G38V) can reverse this suppression (Sethi et al., 1999) . To gain insight into the role of the eector loop of R-Ras in regulating integrin activation we tested the ability of the eector loop mutants to reverse H-Ras suppression using an established integrin activation assay. CHO cells (abpy) stably expressing the active chimeric integrin aIIba6Ab3b1 were transiently transfected with HRas(G12V) alone and in combination with each of the R-Ras mutants. Integrin activation was then determined using a¯ow-cytometry based assay to measure the binding of PAC1, a monoclonal antibody speci®c for the active conformation of the integrin aIIbb3 (Shattil et al., 1985) .
As expected H-Ras(G12V) suppressed integrin activation as judged by a reduction in PAC1 binding, which was reversed by co-transfection of R-Ras(G38V) ( Figure   6a ). The R-Ras eector loop mutants E63G, D64A and Y66C manifested similar activity (Figure 6a ). RRas(D64A) and R-Ras(Y66C) failed to interact with the Ral Guanine nucleotide exchangers, Raf or Nore1 suggesting that neither Ral-GDS or Nore1 are the critical eectors responsible for the reversal of integrin suppression. The (D64E) and (Y66E) mutants of R-Ras failed to reverse H-Ras suppression (Figure 6a ). Western blot analysis revealed that R-Ras(Y66E) was not well expressed with this mutant showing an additional band at 7 kD, an apparent cleavage product (Figure 6b) . Therefore, the (Y66E) mutation introduces a potential cleavage site into R-Ras rendering this variant unstable possibly explaining its inability to reverse H-Ras suppression. In contrast R-Ras(D64E) is stable and well expressed and the failure of this mutant to in¯uence integrin activation is presumably due to an inability to activate the appropriate downstream eector.
We previously found that PI 3-kinase inhibitors failed to block the R-Ras eect on integrins (Sethi et Mutations in the eector binding domain can block the ability of R-Ras to in¯uence integrin anity. ab-py cells were transiently transfected with Tac-a5 alone or Tac-a5 plus 3 mg of an expression vector encoding H-Ras(G12V). In separate transfections, expression vectors encoding H-Ras(G12V) were simultaneously co-transfected with 3 mg of a plasmid encoding RRas(G38V) or an R-Ras eector loop mutation. After 48 h, integrin activation was determined by PAC1 binding to a subset of cells positive for Tac-a5 expression. Depicted is the mean per cent inhibition of integrin activation relative to empty vector control+s.e. of three independent determinations. The panels below show immunoblot analysis of cell lysates illustrating the expression of myc-tagged R-Ras(G38V). Twenty mg of cell lysate from each transfection was separated on a 4 ± 20% gradient gel and immunoblotted with the anti-Myc antibody 9E10. In all conditions at least 25% of all cells were positively transfected as judged by FACS analysis of Tac-a5 expression al., 1999). However, these experiments were limited by the possibility that R-Ras may be capable of aecting the activity of PI 3-kinases that are not sensitive to chemical inhibitors such as LY294002 and wortmannin. However, the observation that the D64A and Y66C mutants are able to eciently activate integrins, but are largely defective in PI 3-kinase activation supported the hypothesis that R-Ras regulates integrin function in CHO cells in a PI 3-kinase independent manner (Figures 2 and 6a) . To con®rm this hypothesis, we sought to determine whether expression of p110aCAAX, an activated variant of p110a (Wennstrom et al., 1999) , could substitute for R-Ras in this assay. As expected p110aCAAX failed to signi®cantly rescue the suppression of integrin activity by HRas(G12V) (Figure 7 ), when transfected alone or in the presence of the eector loop mutant D64E. Furthermore, the p110aCAAX construct caused an 8 ± 16-fold increase in Akt phosphorylation (data not shown). Thus, speci®c mutations in the R-Ras eector binding domain can inhibit both PI 3-kinase activation and integrin activation, however, as judged by the properties of R-Ras eector loop mutants investigated here these two eects do not appear to be linked.
Membrane binding of R-Ras is involved in regulation of integrin activation
As mentioned above, R-Ras in¯uences integrins through a presumptive novel eector. Ecient activation of downstream eectors by Ras GTPases requires membrane targeting through C-terminal isoprenylation and methylation (Seabra, 1998) . To test if the membrane localization of R-Ras was involved in eects on integrins, we generated a mutant RRas(G38V, C215S) in which the prenylated cysteine has been changed to serine. This mutant profoundly reduced the activity of R-Ras(G38V) to modulate integrin activation, and as expected the mutation also reduced membrane localization (Figure 8) . Thus, the ability of R-Ras to interact with membranes is important for its capacity to regulate integrins.
Discussion
The major ®ndings of this paper are as follows. Firstly, individual R-Ras eector loop mutants disrupt the coupling to and activation of speci®c downstream Figure 7 Activated PI 3-kinase does not rescue H-Ras suppression. ab-py cells were co-transfected with expression vectors encoding H-Ras(G12V), R-Ras(G38V), R-Ras(G38V, D64E) and p110-CAAX in the combinations depicted on the X axis. After 48 h, integrin activation was determined by PAC1 binding to a subset of cells positive for Tac-a5 expression. In all conditions at least 25% of all cells were positively transfected as judged by FACS analysis of Tac-a5 expression. Depicted is the mean per cent inhibition of integrin activation relative to empty vector control+s.e. of three independent determinations Figure 8 R-Ras needs to be membrane localized to reverse HRas suppression. ab-py cells were transiently transfected with expression vectors encoding H-Ras(G12V), R-Ras(G38V) and RRas(G38V, C215S) in the indicated combinations and after 48 h integrin activation was analysed by¯ow cytometry by measuring PAC1 binding to a subset of cells positive for Tac-a5 expression. In all conditions at least 25% of all cells were positively transfected as judged by FACS analysis of Tac-a5 expression. Illustrated in the lower panels are the mean activation indices+s.d. of three independent experiments. The upper panels depict immunoblot analysis illustrating the reduction of myctagged R-Ras in a crude-membrane preparation of cells transfected with R-Ras(G38V, C215S). In contrast, R-Ras(G38V) is largely localized in the membrane-fraction eectors. Secondly, we have identi®ed Nore1 as a novel R-Ras interactor and demonstrated that its binding is sensitive to speci®c mutations in the core eector domain of R-Ras. Thirdly, based on the impact of the eector loop mutations on integrin activation, neither Nore1 or Ral-GDS are involved in R-Ras regulation of integrins. In addition, neither pharmacological inhibition of PI 3-kinase nor activated variants of PI 3-kinase modi®ed the integrin response to R-Ras or its eector loop mutants. Thus, the bulk of cellular PI 3-kinase is not the critical R-Ras eector regulating integrin function in CHO cells. Finally, the capacity of R-Ras to modify integrin function requires membrane targeting. These ®ndings are summarized in Table 2 . The studies presented here provide new insight into the structural basis of R-Ras function and suggest the existence of novel mechanisms through which this GTPase regulates cell adhesion.
The coupling of GTP loaded R-Ras to its speci®c downstream eectors is disrupted by speci®c mutations in the core eector region of R-Ras. All of the mutations, with the exception of E63G, markedly reduced the ability of R-Ras to activate PI 3-kinase in COS7 cells. Of the homologous mutations in H-Ras (E37G, D38A, D38E and Y40C), only Y40C is capable of activating PI-3 kinase in this cell type (RodriguezViciana et al., 1997). Thus, there appears to be a striking dierence in the eects of these R-Ras mutations and equivalent H-Ras mutations in coupling to PI 3-kinase. Our results support and extend recent observations suggesting that the R-ras eector loop mutants activate PI 3-kinase dierently from the equivalent mutations in H-Ras (Osada et al., 1999) . Osada et al. proposed that dierences between R-Ras and H-Ras with respect to coupling to PI 3-kinase may re¯ect the fact that non-homologous mutations were used to activate H-Ras and R-Ras, H-Ras(G12V) versus R-Ras(Q87L) respectively. However, in this study we obtained similar results using the activating R-Ras(G38V) mutant, which is homologous to HRas(G12V). Thus, given that both H-and R-Ras share the same core eector domain, the speci®city of interaction with PI 3-kinase may be mediated by dierences in the sequences¯anking the core eector domain, the so-called speci®city regions (Khosravi-Far et al., 1998) . Alternatively, the dierences between HRas and R-Ras could be the result of the activation of distinct isoforms of PI 3-kinase by these two proteins. In support of this hypothesis, recent studies have demonstrated that dierent isoforms of PI 3-kinase couple to H-Ras with dierent binding speci®cities (Kinashi et al., 2000) . Thus, eector loop mutations in R-Ras disrupt coupling to PI 3-kinase in a manner distinct from the eects of similar mutations in H-Ras.
The interaction of R-Ras with Ral guanine nucleotide exchangers was also sensitive to eector loop mutations, in both yeast two-hybrid and far Western analysis. In the yeast two-hybrid system only RRas(E63G) was capable of binding Ral-GDS. Similar results have been reported from studies examining the interaction of H-Ras and Ral-GDS using homologous eector loop mutations. Only H-Ras (E37G), the homologous mutation to R-Ras (E63G), binds Ral-GDS . Thus, it appears that H-Ras and R-Ras couple to Ral-GDS in a similar manner.
Nore1 is a novel R-Ras interactor and its binding is sensitive to speci®c mutations in the core eector domain of R-Ras. We used a yeast two-hybrid screen to search for additional R-Ras eectors and isolated Nore1. Nore1 was originally found in a yeast twohybrid screen with H-Ras(V12). It is a ubiquitously expressed 46 kD protein containing a potential diacylglycerol/phorbol-ester binding site (amino acids 118 ± 165), a N-terminal proline rich region, which contains potential SH3 domain binding sites and a Ras-associated domain (RA). Stimulation of COS-7 cells by EGF leads to binding of Nore1 to H-Ras (Vavvas et al., 1998) . However, no biological function has yet been ascribed to Nore1. Other R-Ras eectors with a RA domain include the RalGEFs, Ral-GDS (Spaargaren and Vischo, 1994) , Rgl II (Peterson et al., 1996) and Rlf (Wolthuis et al., 1996) . We also isolated these proteins in both our yeast two-hybrid screens using R-Ras (G38V) as a bait. When we tested the eect of mutations in the R-Ras eector loop on the R-Ras-Nore1 interaction, only the R-Ras(V38, E63G) was capable of binding Nore1. This suggests that eectors with a RA domain may be very sensitive to mutations, in the eector binding domain of R-Ras. Thus, in vitro Nore1 is a novel interactor for R-Ras and its binding to R-Ras is disrupted by eector core region mutations of R-Ras.
Mutations in the eector region of R-Ras disrupt the downstream signaling involved in regulating integrins. As shown previously suppression of integrin anity by H-Ras is reversed by R-Ras(V38). R-Ras mutants (E63G, D64A, Y66C) were as active as R-Ras(V38) in regulating integrins, however the two mutations D64E and Y66E lead to a loss of function.
It has been proposed that the stimulation of the ephrin receptor tyrosine kinase, EphB2 can inhibit integrin function via the phosphorylation of R-Ras on a highly conserved tyrosine in the eector binding domain (Zou et al., 1999) . R-Ras (Y66E) is unable to stimulate the adhesion of 293T cells to ®bronectin and collagen, as the glutamic acid for tyrosine substitution may mimic the eects of the phosphorylation of R-Ras at Y66 (Zou et al., 1999) . Thus, the inability of Y66E to regulate integrin function in CHO cells is consistent with these observations. However, analysis of the expression of Y66E by immunoblotting suggests that the inactivity of this mutant in our experiments could be due to its instability. In contrast, the D64E mutant is well expressed in vivo and appears to activate PI 3- The R-Ras Y66E was not tested for the interaction with downstream eectors because of the instability of this mutant protein (see Figure  6b) . ++=approximately equivalent to R-Ras (G38V), +=weak, but detectable activity. ND=not determined kinase, albeit weakly. Therefore, the D64E mutation likely disrupts the binding of R-Ras to an eector mediating the rescue of Ras suppression. PI 3-kinase activation does not correlate with integrin regulation in CHO cells. We have previously demonstrated that the activation of a LY294002 sensitive PI 3-kinase by R-Ras does not in¯uence integrin anity in CHO cells (Sethi et al., 1999) . However, in this study we could not exclude the possibility that a PI 3-kinase isoform, that is insensitive to LY294002, is responsible for the eects of R-Ras on integrin function (Sethi et al., 1999) . To test this possibility we examined if an active variant of PI 3-kinase alpha, p110aCAAX was able to rescue the suppression of integrin activation.
The observation that p110aCAAX was unable to in¯uence integrin activation further supports the hypothesis that PI 3-kinase activation alone is not responsible for the regulation of integrin function in CHO cells. This is an interesting result in light of the observations made in other cell types on the role of PI 3-kinase in R-Ras stimulated cell adhesion. In mouse myeloid cells R-Ras stimulated adhesion to ®bronectin is largely blocked by inhibitors of PI 3-kinase, indicating a critical role for this eector (Osada et al., 1999) . However, in bone marrow derived mast cells R-Ras(G38V) induced a5b1-dependent adhesion to ®bronectin is not sensitive to PI 3-kinase inhibitors (Kinashi et al., 2000) . Therefore, depending on the cell type R-Ras can regulate integrin function via both PI 3-kinase -dependent and -independent pathways. R-Ras requires membrane targeting to optimally modify integrin function. Ras proteins are targeted to cellular membranes via the isoprenylation and methylation of a C-terminal cysteine residue. Signi®cantly, membrane localization is essential for these proteins to eciently activate their downstream eectors (Magee and Marshall., 1999) . The mutant R-Ras(C215S) manifests a reduced ability to in¯uence integrin activation. The mutation of the prenylation site in RRas prevented its ecient targeting to the membrane and the majority of the R-Ras(C215S) mutant is found in the cytosol. Therefore, membrane targeting is necessary for R-Ras to exert its biological eects on integrins.
In summary, to gain insight into the regulation of integrin function by R-Ras we performed an analysis of R-Ras variants containing mutations in the eector binding domain and C-terminal prenylation site. We found that the activation of the downstream eector PI 3-kinase was sensitive to mutations in the eector binding domain, as was the binding to the eectors, Ral-GDS, Raf-1 and the novel eector Nore1. Furthermore, speci®c mutations in the eector binding loop and C-terminal prenylation motif impaired the ability of R-Ras to regulate integrin function in CHO cells. However, the ability of the RRas eector loop mutants to bind, and activate known eectors did not correlate with their ability to regulate integrin function. Consequently, these studies provide insight into the structural basis of the interactions between R-Ras and its candidate eectors and suggest the existence of novel mechanisms through which this GTPase could regulate cell adhesion.
Materials and methods
Antibodies and reagents
The activation-dependent anti-a IIb b 3 monoclonal antibodies PAC1 (Shattil et al., 1985) and anti-LIBS6 have previously been described (O'Toole et al., 1994) . The anti-Tac antibody 7G7B6 was obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA) and was biotinylated with biotin-N-hydroxysuccinimide (Sigma, St. Louis, MO, USA). The a IIb b 3 -speci®c peptidomimetic inhibitor Ro43-5054 was a generous gift of Dr Beat Steiner (Homann-LaRoche, Basel, Switzerland).
cDNA constructs, cell lines and transfection
The mammalian expression vectors encoding H-Ras(G12V), R-Ras(G38V), HA-Akt, HA-ERK2 and p110-CAAX have been described (Sethi et al., 1999; Hughes et al., 1997; Wennstrom and Downward, 1999) . The pSG5 plasmids encoding the R-Ras eector loop mutants were constructed by site-directed mutagenesis using the Stratagene Quick Change kit (Stratagene, La Jolla, CA, USA). Gal4 DNAbinding domain fusion's of R-Ras(G38V) and the various RRas(G38V) eector-loop mutants were constructed by PCR using the appropriate pSG5-R-Ras plasmid as a template. The ampli®ed DNA was ligated into the EcoRI site of pGBT9 (Clontech, Palo Alto, CA, USA). In all of the pGBT9 R-Ras constructs the C-terminal 20 amino acids were deleted to remove the R-Ras plasma-membrane targeting motifs. A plasmid encoding a Gal4 activation domain fusion of the raf-1 Ras binding domain was constructed by ligating a DNA fragment corresponding to residues 51 ± 131 of Raf-1 into a EcoRI cut pGAD424 vector. The yeast expression vectors encoding H-Ras (Q61L), pGBT9-H-Ras(Q61L)DCVLS, and the Ras-binding domain of Ral-GDS, pGADGH-Ral-GDSD98, were a generous gift of Dr Steve Martin (University of California, San Francisco, CA, USA) (Hofer et al., 1994) .
To generate bacterial expression vectors the appropriate insert was cloned into EcoRI cut pGEXT2K vector (Pharmacia, Piscataway, NJ, USA), with the exception of PGEXT2K R-Ras(G38V) which was obtained by subcloning the R-Ras(G38V) cDNA from pGEX2T-R-Ras(G38V) (a generous gift of Dr Alan Hall, University College, London, UK) into pGEXT2K as a EcoRI-BamHI fragment. GSTfusion proteins were produced and puri®ed according to the manufacturer's instructions (Pharmacia). All DNA constructs were veri®ed by DNA sequencing.
CHO-K1 cells were obtained from the ATCC (American Type Culture Collection). The generation of CHO ab-py cells has been described previously (Baker et al., 1997) . All cells were cultured in DMEM (BioWhittaker, Walkersville, MD, USA) containing 10% FCS, 1% non-essential amino acids, 2 mM glutamine (Sigma), 100 U/ml penicillin and 100 mg/ml streptomycin. CHO and COS7 cells were transiently transfected using Lipofectamine (Gibco BRL) as described previously (Sethi et al., 1999) .
Flow cytometry
PAC1 binding was determined by two-color¯ow-cytometry as described previously (Hughes et al., 1997) . Brie¯y, 48 h after transfection cells were harvested by a brief trypsinization and washed in DMEM/1% BSA. 5610 5 cells were incubated with 0.1% PAC1 ascites in the presence of the competitive inhibitor Ro43-5054 at 1 mM or anti-LIBS6 ascites. After 30 min incubation at room temperature cells were washed with cold DMEM/1% BSA and incubated with the biotinylated anti-Tac antibody 7G7B6 for 30 min on ice. After washing, cells were incubated with 10% FITCconjugated goat anti-mouse IgM (TAGO) and 4% phycoerythrin-streptavidin (Molecular Probes Inc.) for another 30 min on ice. Cells were washed in ice-cold PBS and resuspended in PBS. Then cells were analysed on a FACScan (Becton Dickinson)¯ow cytometer as described (Hughes et al., 1997) and the collected data were analysed using CellQuest software (Becton Dickinson). To obtain numerical estimates of integrin activation we calculated an activation index, as described (Hughes et al., 1997) . The percentage inhibition was calculated as 100(AI o 7AI)/AI o , where AI o is the activation index in the absence of the co-transfected test cDNA, and AI is the activation index in its presence.
Measurement of ERK2 and Akt activity
HA-Akt kinase activity was assayed using an immunocomplex kinase assay as described (Sethi et al., 1999) . Forty-eight hours after transfection, cells were lysed with 1.0% NP40 in a buer containing both phosphatase and protease inhibitors. The HA-Akt was immunoprecipitated with the 12CA5 antibody, the precipitates were then washed and immuno-complex kinase assays were performed using histone 2B as an Akt substrate . Phosphorylated Akt was detected by fractionating 20 mg of whole cell lysate on a 4 ± 20% SDS-polyacrylamide gels, transferring to nitrocellulose membranes and immunoblotting with the polyclonal anti-phospho Akt antibody, AktS473 (New England Biolabs). The blots were then stripped and immunoblotted with the anti-HA antibody 12CA5 to determine the amount of HA-Akt present in each of the lysates.
ERK2 kinase assays were undertaken as described . COS7 cells were transfected using Lipofectamine (Gibco ± BRL) with 2 mg of pCMV5 HA-ERK2 in combination with the test plasmid. The HA-ERK2 was immunoprecipitated with the 12CA5 antibody, the precipitates were then washed and kinase assays were performed using myelin basic protein (MBP) as a substrate.
Yeast-two-hybrid analysis
The yeast strain Y190 (Saccharomyces cerevisiae Y190 strain) was used for the yeast two hybrid screens. We screened two dierent libraries, a human B-cell library (a generous gift of Dr S Shattil) and a 3T3 ®broblast library, which was a generous gift by Dr P Maher (Scripps Research Institute, La Jolla, CA, USA). The screens were done according to a standard protocol (Gietz et al., 1997 
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7 selection media for 4 to 5 days. The interaction between prey and bait was assessed by both growth and a bgalactosidase assay. Six independent colonies from each transfection were replated on Leu 7 Trp 7 selection media for 3 days and transferred to nitrocellulose ®lters. The yeast on the ®lters were then assayed for b-galactosidase activity. In addition liquid assays were also performed to measure bgalactosidase activity.
Far Western blotting
As an alternative to yeast two-hydrid analysis we used a ligand blotting technique to assay interactions between RRas and candidate eectors (Park and Weinberg, 1995) .
Brie¯y, GST-fusion proteins of R-Ras and H-Ras were expressed and puri®ed according to the manufacturer's instructions (Pharmacia, Piscataway, NJ, USA). To determine the functionality of these recombinant proteins we examined their ability to bind [ 3 H]-GTP, as described (Lai et al., 1993) .
Brie¯y, 5 mg of whole cell lysates from E. Coli strain DH5a expressing GST fusion proteins of the Raf-1 or Ral-GDS Ras binding domain were resolved on a 4 ± 20% SDS ± PAGE gel and transferred to nitrocellulose. The transferred proteins were denatured, renatured and blocked in hybridization solution as described (Takayama and Reed, 1997) . Brie¯y, the ®lters were placed in 20 ml of HBB (25 mM HEPES, pH 7.7, 25 mM NaCl, 5 mM MgCl 2 , 0.5 mM DTT) containing 6 M guanidine hydrochloride and incubated twice at 48C with rocking for 10 min. The membranes were then washed four times at 48C with 10 ml of fresh HBB solution. After the ®nal wash, the ®lters were immersed in 5 ml of fresh HBB solution and incubated at 48C for 5 min. Filters were then blocked for 1 h at 48C in Hyb-75 buer (20 mM HEPES, pH 7.7, 75 mM KCl, 0.1 mM EDTA, 2.5 mM MgCl 2 , 1 mM DTT, 0.05% NP-40) with 5% nonfat milk with gentle rocking.
The expression constructs for the various GST-R-Ras and GST-H-Ras fusion proteins contain a consensus protein kinase A phosphorylation site at their N-terminus which allows them to be labeled with 32 P in vitro. It should be noted that neither R-Ras or any of the eector loop mutants contain consensus protein kinase A phosphorylation sites. Puri®ed GST-R-Ras and GST-H-Ras proteins were labeled with 32 P using protein kinase A according to manufacturer's instructions (Pharmacia, Piscataway, NJ, USA) and following blocking, ®lters were hybridized for 2 h at 48C in Hyb-75 buer/1% nonfat milk powder containing either 32 P-labeled R-Ras or H-Ras protein probes in the presence of 1 mM GTP and a 50 M excess of GST. Filters were then washed three times for 10 min per wash at 48C in Hyb-75/1% nonfat milk powder and exposed to X-ray ®lm.
Crude membrane preparation
Crude cell membranes were isolated as follows. Forty-eight hours after transient transfection cells were washed twice with PBS and scraped into 10 ml of Buer A (5 mM HEPES, 4 mM EDTA, pH 7.4, containing a cocktail of standard protease inhibitors). The cells were homogenized 10 times with a 20 gauge needle. The sheared cells were then centrifuged at 2000 r.p.m. for 10 min; the supernatant was removed and centrifuged again for 40 min at 16000 r.p.m. The supernatant was discarded and the resulting membrane pellet resuspended in 200 ml Buer B (1 M HEPES, 0.5 M EDTA, pH 7.4) and passed 10 times through a 22 gauge needle.
